Loading stock data…
$44.97-0.58 (-1.27%)
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
CONMED Corporation in the Healthcare sector is trading at $44.97 with a market capitalization of $1.5B. Wall Street consensus targets $45.50 (6 analysts), implying a +1.2% move over the next 12 months. The stock is currently 16% below its 52-week high of $53.66, remaining 9.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $343.49M↑ | $317.05M↓ | $373.20M↑ | $337.93M↓ | $342.35M |
| Gross Profit | $197.46M↑ | $183.45M↓ | $218.28M↑ | $166.12M↓ | $188.32M |
| Operating Income | $36.41M↑ | $25.41M↓ | $36.62M↑ | $11.88M↓ | $38.16M |
| Net Income | $23.07M↑ | $13.83M↓ | $16.74M↑ | $2.86M↓ | $21.42M |
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation...